课题基金 / 基金详情

The invention of the intellectualization cytokine using a synthetic biological response modifier.

The invention of the intellectualization cytokine using a synthetic biological response modifier.
使用合成生物反应调节剂的智能化细胞因子的发明。
批准号:
11672259
负责人:
KUBO Kazuyoshi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

KUBO Kazuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to further explore the usefulness of conjugation with functional polymeric modifiers for clinical application of bioactive proteins and to increase the therapeutic efficacy of tumor necrosis factor alpha (TNF-alpha) by conjugation in vivo. We synthesized TNF-alpha conjugated with the copolymer of divinyl ether and maleic anhydride (DIVEMA), which has intrinsic antitumor activity as a synthetic biological response modifier. The synthesis of DIVEMA-TNF-alpha could be controlled by the addition of 2,3-dimethylmaleic anhydride (DMMAn), which binds to or separates from amino groups when the pH is changed. The specific activity of DIVEMA-TNF-alpha (+) synthesized with DMMAn was hardly decreased in vitro. However, DIVEMA-TNF-alpha (-), which is conjugated without blocking by DMMAn, had a markedly diminished specific activity. DIVEMA-TNF-alpha (+) caused a dramatic hemorrhagic necrotic effect on the tumor when compared to native TNF-alpha 24 h after i.v. injection into mice bearing Sarcoma-180 solid tumors. In addition, DIVEMA-INF-alpha (+) at a dose of only 100 Japan reference units per mouse revealed a dramatic antitumor effect that is approximately 100 times greater than native TNF-alpha and that could induce complete regression in all five mice bearing Meth-A solid tumors without any apparent side effects. Because neither DIVEMA alone nor a mixture of TNF-alpha and DIVEMA caused antitumor activity with i.v. administration, the increase in antitumor potency of TNF-alpha may be caused by the covalent conjugation with DIVEMA.DIVEMA-TNF-alpha at low dose revealed dramatic antitumor potency. Because TNF-alpha injected in vivo is extremely low-dose, concentration of intrinsic TNF-alpha in vivo is not influenced. Therefore, the cytokine network in vivo is not destroyed. These results suggest that DIVEMA is a useful polymeric modifier for conjugation of TNF-alpha to increase its antitumor activity.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Mu Y.et al.: "Bioconjugation of bioactive peptide : synthetic peptide YIGSR conjugated with poly (styrene co-maleic acid) enhanced its inhibitory effect on lung metastasis of B16BL6 melanoma cells."Drug Delivery System. 14. 129-135 (1999)
Mu Y.等人:“生物活性肽的生物缀合:合成肽YIGSR与聚(苯乙烯共马来酸)缀合增强了其对B16BL6黑色素瘤细胞肺转移的抑制作用。”药物输送系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsunoda S.et al.: "Enhanced antitumor potency of PEGylated tumor necrosis factor-a : a novel polymer-conjugation technique with a reversible amino-protective reagent."J.Pharmacol.Exp.Ther.. 290. 368-372 (1999)
Tsunoda S.等人:“聚乙二醇化肿瘤坏死因子-a 的增强抗肿瘤效力:一种具有可逆氨基保护试剂的新型聚合物缀合技术。”J.Pharmacol.Exp.Ther.. 290. 368-372 (1999
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Haruhiko Kamada: "Molecular design of conjugated tumor necrosis factor-alpha; Synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis facyor-alpha"Biochem. Biophys. Res. Commun.. 257(2). 448-453 (1999)
Haruhiko Kamada:“缀合肿瘤坏死因子-α的分子设计;聚乙烯吡咯烷酮修饰的肿瘤坏死因子-α的合成和特性”Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mu Y.: "Bioconjugation of bioactive peptide : synthetic peptide YIGSR conjugated with poly (styrene co-maleic acid) enhanced its inhibitory effect on lung metastasis of B16BL6 melanoma cells."Drug Delivery System. 14. 129-135 (1999)
Mu Y.:“生物活性肽的生物缀合:合成肽YIGSR与聚(苯乙烯共马来酸)缀合增强了其对B16BL6黑色素瘤细胞肺转移的抑制作用。”药物输送系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    A study and challenging realization of engineering education applicable to ABET in the field of electronic control engineering
    • 批准号:
      24653284
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      KUBO Kazuyoshi
    • 依托单位:
    The novel synthesis of controlled release polymer with targeting function and application to DDS.
    • 批准号:
      11557193
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $6.46万
    • 财政年份:
      1999
    • 负责人:
      KUBO Kazuyoshi
    • 依托单位:
    Development and evaluation of novel biodegradable transdermal penetration enhancers
    • 批准号:
      09672281
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      KUBO Kazuyoshi
    • 依托单位:
    海外基金